Study of spontaneous apoptosis in HIV+ patients: Correlation with clinical progression and T cell loss

AIDS Research and Human Retroviruses

Volumn 13, Issue 17, 1997, Pages 1501-1508

  Prati, Enrica ^a   Gorla, Roberto ^a   Malacarne, Fabio ^a   Airò, Paolo ^a   Brugnoni, Duilio ^a   Gargiulo, Franco ^a   Tebaldi, Alessandra ^a   Castelli, Francesco ^a   Carosi, Giampiero ^a   Cattaneo, Roberto ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CELL LOSS; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030825850     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1501     Document Type: Article

References (35)

1. Ameisen JC and Capron A: Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol Today 1991;12:102-105.
2. Terai C, Kornbluth RS, Pauza D, Richman DD, and Carson D: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;87:1710-1715.
3. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekali RP, and Finkel T: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-1106.
4. Gougeon M, Garcia S, Heeney J, Tschopp R, Lecoeur H, Guetard D, Rame V, Dauguette R, and Montagnier L: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993;9:553-563.
5. Lewis DE, Ng-Tang DS, Adu-Oppong A, Schober W, and Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 1994;153:412-420.
6. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, and Miedema F: Programmed cell death of T cells in HIV-1 infection. Science 1992;257:217-219.
7. Meyaard L, Otto SA, Keet RP, Roos MTL, and Miedema F: Programmed cell death of T cells in human immunodeficiency virus infection: No correlation with progression to disease. J Clin Invest 1994;93:982-988.
8. Gougeon ML, Olivier R, Garcia S, Guetard D, Dragic T, Dauguette C, and Montagnier L: Mise en évidence d'un processus d'engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectés par le VIH. CR Acad Sci Paris 1991;312:529-537.
9. Gorla R, Imberti L, Prati E, Brugnoni D, Caligaris S, Cattaneo R, Albertini A, and Primi D: Differential priming to programmed cell death of superantigen-reactive lymphocytes of HIV patients. AIDS Res Hum Retroviruses 1994;10:1097-1103.
10. Groux H, Torpier G, Monté D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
11. Oyaizu N, Mccloskey TW, Coronesi M, Chirmule N, Kalyanamaran VS, and Pahwa S: Accelerated apoptosis in peripheral blood menonuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 1993;82:3075-3080.
12. Pandolfi F, Oliva A, Sacco G, Polidori V, Liberatore D, Mezzaroma I, Giovannetti A, Kurnick JT, and Aiuti F: Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS 1993;7:323-329.
13. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, and Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1995;1:129-134.
14. Margolick JB, Munoz A, Donneberg AD, Park LP, Galai N, Giorgi JV, O'Gorman MRG, and Ferbas J: Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Med 1995;1:674-680.
15. Gougeon ML, Lecour H, Duliost A, Enouf MG, Crouvoisier M, Goujard C, Debord T, and Montagnier L: Programmed cell death in peripheral lymphocytes from HIV-infected persons. J Immunol 1996;156:3509-3520.
16. Pandolfi F, Picrdominici M, Oliva A, D'Offizi G, Mezzaroma I, Mollicone B, Giovannetti A, Rainaldi L, Quinti I, and Aiuti F: Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:450-458.
17. Center for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
18. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
19. Tsoukas CM and Bernard NF: Markers predicting of human immunodeficiency virus-related disease. Clin Microbiol Rev 1994;7:14-28.
20. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
21. Schuitemaker H, Meyaard L, Koostra NA, Dubbes R, Otto SA, Tersmatte M, Heeney JL, and Miedema F: Lack of T-cell dysfunction and programmed cell death correlates with inability of HIV-1 to infect chimpanzee monocytes. J Infect Dis 1993;168:1190-1197.
22. Yang E and Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 1996;88:386-401.
23. Boudet F, Lecoeur H, and Gougeon ML: Apoptosis associated with ex vivo down-regulation of bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 1996;156:2282-2293.
24. Adachi Y, Oyazu N, Than S, McCloskey TW, and Pahwa S: IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. J Immunol 1996;157:4184-4193.
25. Katsikis PD, Wunderlich ES, Smith CA, and Herzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995;181:2029-2036.
26. Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM, and Ameisen JC: T helper type 1/T helper type 2 cytokines and T cell death: Preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995;182:1759-1767.
27. Lauener RP, Huttner S, Buisson M, Hossle JP, Seigneurin JM, Seger RA, and Nadal D: T-cell death by apoptosis in vertically human immunodeficiency virus-infected children coincides with expansion of CD8+/interleukin-2 receptor-/HLA-DR+ T cells: Signs of a possible role for herpes viruses as a cofactor? Blood 1995;86:1400-1407.
28. Oehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, and Erb P: The Fas receptor in HIV infection: Expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996;10:9-16.
29. Silvestris F, Cafforio P, Frassanito MA, Tucci M, Romito A, Nagata S, and Dammacco F: Overexpression of Fas antigen on T cells in advanced HIV-1 infection: Differential ligation constantly induces apoptosis. AIDS 1996;10:131-141.
30. - cells. AIDS 1996;10: 104-106.
31. Roos MTL, Lange JMA, De Geode REY, Coutinho RA, Schelleken PT, Miedema F, and Tersmette M: Virus phenotype and immune response in primary human immunodeficiency virus type 1 (HIV-1) infection. J Infect Dis 1992;165:427-432.
32. Borthwick NJ, Bofill M, Hassan I, Panayiotidis P, Janossy G, Salmon M, and Akbar AN: Factors that influence activated CD8+ T cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-x expression. Immunology 1996;88: 508-515.
33. Uehara T, Miyawaki T, Ohta K, Tamaru Y, Yokoi T, Nakamura S, and Taniguchi N: Apoptotic cell death of primed CD45R0+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 1992;80:452-459.
34. - T cells. AIDS 1994;8:431-441.
35. Muro-Cacho CA, Pantaleo G, and Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995;154:5555-5566.